Kahira Pharmaceuticals and Chemical Industries Co

مادة اعلانية

Latest Update: 17 Sep 2024 14:05 Abu Dhabi Time.

Market Status: Closed

CPCI

Kahira Pharmaceuticals and Chemical Industries Co

73.80

EGP

-0.010

-0.01%

Open

73.81

Prev Close

73.81

PX_VOLUME

335

MARKET CAP (M)

1,102.31

DAY RANGE

72.41 - 73.80

52 WEEKS

37.15 - 83.00

Stock Statistics

Yearly Change

83.20%

Listed Shares (Million)

14.93

Earnings Multiple

4.67

Average 30-day trading volume

6,072.31

Price-to-book ratio

1.40

Earnings Per Share

6.50

Previous Dividend Distribution

4.75

Dividend Yield

7.25%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022
Total Revenue		336.36	373.44	335.32	339.69	214.52	198.93
Gross Profit		123.33	115.67	111.22	105.53	35.91	15.07
Operating Income		84.63	83.40	80.29	65.54	-7.73	-8.67
Profit Margin		22.16	16.43	17.65	12.08	2.78	5.67

	Period Ending:	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Total Revenue		1,005.24	1,112.11	1,062.05	1,010.43	962.94
Gross Profit		237.30	326.95	268.13	260.41	229.64
Operating Income		100.14	221.07	173.79	164.01	132.09
Profit Margin		9.66	14.90	11.70	10.80	8.84

Balance Sheet

	Period Ending:	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022
Total Assets		1,545.31	1,375.83	1,291.46	1,261.27	1,383.73	1,339.95
Total Liabilities		758.49	654.34	545.83	574.81	634.42	596.55
Total Equity		786.82	721.49	745.64	686.46	749.31	743.40

	Period Ending:	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Total Assets		1,261.27	1,168.89	1,068.47	988.13	1,056.05
Total Liabilities		574.81	374.95	364.74	334.38	452.39
Total Equity		686.46	793.94	703.73	653.76	603.66

Cash Flows Statements - Coming Soon

* In Million of Egypt Pound

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.

CPCI

Kahira Pharmaceuticals and Chemical Industries Co